<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors analysed the effectiveness of Lipanthyl treatment in 38 patients after <z:hpo ids='HP_0001297'>stroke</z:hpo> undergoing rehabilitation treatment </plain></SENT>
<SENT sid="1" pm="."><plain>The effects of the drug were evaluated on the general condition, neurological and psychic status, progression of motor rehabilitation, and on <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism parameters </plain></SENT>
<SENT sid="2" pm="."><plain>A statistically significant improvement was obtained in the subjective and psychic condition, and the results of motor rehabilitation were slightly better than in the compared groups of patients </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="23" ids="18059">Lipid</z:chebi> metabolism was normalized only in part (cholesterol, chylomicrons) </plain></SENT>
<SENT sid="4" pm="."><plain>In the conclusions the authors state that it is useful to give this drug to patients with cerebral <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> only if disturbances of <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism coexist with this disease and are refractory to dietetic treatment </plain></SENT>
</text></document>